Characterization of drug interactions with serum proteins by using high-performance affinity chromatography

Current Drug Metabolism

Volumn 12, Issue 4, 2011, Pages 313-328

  Hage, David S ^a   Anguizola, Jeanethe ^a   Barnaby, Omar ^a   Jackson, Abby ^a   Yoo, Michelle J ^a   Papastavros, Efthimia ^a   Pfaunmiller, Erika ^a   Sobansky, Matt ^a   Tong, Zenghan ^a  

^a UNIVERSITY OF NEBRASKA LINCOLN   (United States)

Author keywords

Drug protein binding; High performance affinity chromatography; High throughput screening; Human serum albumin; Lipoproteins; Personalized medicine

Indexed keywords

ACETYLDIGITOXIN; AMINOALCOHOL; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CLOMIFENE; COUMARIN DERIVATIVE; DIGITOXIN; HIGH DENSITY LIPOPROTEIN; HUMAN SERUM ALBUMIN; IBUPROFEN; LEVOTHYROXINE; LOW DENSITY LIPOPROTEIN; OROSOMUCOID; PHENYLBUTAZONE; PHENYTOIN; PROPIONIC ACID DERIVATIVE; PROPRANOLOL; QUINOLINE DERIVATIVE; SCHIFF BASE; SILICON DIOXIDE; TOLBUTAMIDE; TRYPTOPHAN; VERAPAMIL; VERY LOW DENSITY LIPOPROTEIN; VINCA ALKALOID; WARFARIN;

AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING AFFINITY; BINDING SITE; CHIRALITY; DRUG COMPETITION; DRUG ISOLATION; DRUG PROTEIN BINDING; ELUTION; ENTHALPY; ENTROPY; EQUILIBRIUM CONSTANT; HIGH PERFORMANCE AFFINITY CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; IONIC STRENGTH; MATHEMATICAL MODEL; PH; PROTEIN BLOOD LEVEL; PROTEIN IMMOBILIZATION; TEMPERATURE;

EID: 79953665313     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920011795202938     Document Type: Article

References (183)

1. Kwong, T. C. Free drug measurements: methodology and clinical significance. Clin. Chim. Acta, 1985, 757, 193-216. (Pubitemid 16238740)
2. Svensson, C. K.; Woodruff, M. N.; Baxter, J. G.; Lalka, D. Free drug concentration monitoring in clinical practice. Rationale and current status. Clin. Pharmacokin., 1986, 77, 450-469. (Pubitemid 17203068)
3. Kratochowil, N. A.; Huber, W.; Muller, F.; Kansy, M.; Gerber, P. R. Predicting plasma protein binding of drugs: a new approach. Biochem. Pharmacol., 2002, 64, 1355-1374. (Pubitemid 35248253)
4. Chan, S.; Gerson, B. Free drug monitoring. Clin. Lab. Med., 1987, 7, 279-287. (Pubitemid 17113979)
5. Barre, J.; Didey, F.; Delion, F.; Tillement, J. P. Problems in therapeutic drug monitoring: free drug level monitoring. Ther. Drug Monit., 1988, 70, 133-143. (Pubitemid 18098680)
6. Krueger-Thiemer, E.; Buenger, P. Role of therapeutic regimen in dosage design. Chemotherapia, 1965, 70, 61-73.
7. th ed.; Gilman, A. G.; Rall, T. W.; Nies, A. S.; Taylor, P., Eds.; Pergamon Press: New York, 1990.
8. Lindup, W. E. In: Progress in Drug Metabolism; Bridges, J.W.; Chasseaud, L. F.; Gibson, G.G., Eds.; Taylor & Francis: New York, 1987; Vol. 70, pp.141-185.
9. Peters, T., Jr., All About Albumin: Biochemistry, Genetics and Medical Applications, Academic Press: New York, 1996.
10. Wainer, I. W. The impact of new liquid chromatography chiral stationary phase technology on the study of stereoselective phar-macokinetics. Trends Anal. Chem., 1993, 72, 153-158. (Pubitemid 23147354)
11. Carter, D. C.; Ho, J. X. Structure of serum albumin. Adv. Prot. Chem., 1994, 45, 153-203. (Pubitemid 24139888)
12. Hage, D. S.; Tweed, S. A. Recent advances in chromatographic and electrophoretic methods for the study of drug-protein interactions. J. Chromatogr. B, 1997, 699, 499-525. (Pubitemid 27473726)
13. Herve, F.; Urien, S.; Albengres, E.; Duche, J. C.; Tillement, J. P. Drug binding in plasma. A summary of recent trends in the study of drug and hormone binding. Clin. Pharmacokin., 1994, 26, 44-58. (Pubitemid 24029186)
14. nd ed.; Hage, D.S., Ed.; Taylor & Francis: New York, 2006; Chap. 22.
15. nd ed.; Hage, D.S., Ed.; Taylor & Francis: New York, 2006; Chap. 24.
16. Heinze, A.; Holzgrabe, U. Protein bonding of drugs. Rapid determination by means of continuous ultra filtration. Bioforum, 2005, 28, 21-23.
17. Zhirkov, Y. A.; Piotrovskii, V. K. On the usefulness of ultrafiltration in drug-protein binding studies. J. Pharm. Pharmacol., 1984, 36, 844-845. (Pubitemid 15222003)
18. Whitlam, J. B.; Brown, K. F. Ultrafiltration in serum protein binding determinations. J. Pharm. Sci., 1981, 70, 146-150. (Pubitemid 11131216)
19. Xie, M.; Long, M.; Liu, Y.; Qin, C.; Wang, Y. Characterization of the interaction between human serum albumin and morin. Biochim. Biophys. Acta, 2006, 1760, 1184-1191. (Pubitemid 43928259)
20. Liu, S.; Zhang, L.; Zhang, X. Interaction between fluoroquinolones and bovine serum albumin studied by affinity capillary electrophoresis. Anal. Sci., 2006, 22, 1515-1518.
21. Jia, Z. Physicochemical profiling by capillary electrophoresis. Curr. Pharm. Anal., 2005, 7, 41-56.
22. nd ed.; Hage, D.S., Ed.; Taylor & Francis: New York, 2006; Chap. 26.
23. Liu, X.; Chen, X.; Yue, Y.; Zhang, J.; Song, Y. Study of interaction between drug enantiomers and human serum albumin by flow injection-capillary electrophoresis frontal analysis. Electrophoresis, 2008, 29, 2876-2883. (Pubitemid 352006121)
24. Erim, F. B.; Kraak, J. C. Vacancy affinity capillary electrophoresis to study competitive protein-drug binding. J. Chromatogr. B, 1998, 770, 205-210. (Pubitemid 28318154)
25. Busch, M. H. A.; Carels, L. B.; Boelens, H. F. M.; Kraak, J. C.; Poppe, H. Comparison of five methods for the study of drug- protein binding in affinity capillary electrophoresis J. Chromatogr. A, 1997, 777, 311-328. (Pubitemid 27362254)
26. Kim, H.; Austin, J.; Hage, D. S. Identification of drug-binding sites on human serum albumin using affinity capillary electrophoresis and chemically modified proteins as buffer additives. Electrophoresis, 2002, 23, 956-963. (Pubitemid 34285401)
27. Day, Y. S. N.; Myszka, D. G. Characterizing a drug's primary binding site on albumin. J. Pharm. Sci., 2003, 92, 333-343. (Pubitemid 36169306)
28. Sulkowska, A.; Bojko, B.; Rownicka, J.; Rezner, P.; Sulkoxski, W.W. The competition of drugs to serum albumin in combination chemotherapy: NMR study. J. Mol. Struct., 2005, 744-747, 781-787. (Pubitemid 40722030)
29. Shortridge, M. D.; Mercier, K. S.; Hage, D. S.; Harbison, G. S.; Powers, R. Estimating protein-ligand binding affinity using high- throughput screening by NMR. J. Combin. Chem., 2008, 70, 948-958.
30. Hage, D.S. High-performance affinity chromatography: a powerful tool for studying serum protein binding. J. Chromatogr. B, 2002, 768, 3-30. (Pubitemid 34142293)
31. Walters, R. R. Affinity chromatography. Anal. Chem., 1985, 57, 1099A-1101A.
32. nd ed.; Taylor & Francis: New York, 2006.
33. Ettre, L.S. Nomenclature for chromatography. Pure Appl. Chem., 1993, 65, 819-872.
34. st ed.; CRC Press, Boca Raton, 1987.
35. nd ed.; Hage, D.S., Ed..; Taylor & Francis: New York, 2006; Chap. 23.
36. Schiel, J.E.; Joseph, K.S.; Hage, D.S. In: Advances in Chromatog- raphy, Vol. 48; Grinsberg, N.; Grushka, E., Eds.; Taylor & Francis: New York, 2009; Chap. 4.
37. 1-acid glycoprotein for chromatographic studies of drug-protein binding. Anal. Biochem., 2005, 346, 300-310. (Pubitemid 41550261)
38. Xuan, H.; Hage, D. S. Evaluation of a hydrazide-linked alpha i- acid glycoprotein chiral stationary phase: separation of R- and S- propranolol. J. Sep. Sci., 2006, 29, 1412-1422. (Pubitemid 44122009)
39. 1-acid glycoprotein for chiral separations. J. Chromatogr. A., 2007, 1149, 294-304. (Pubitemid 46627653)
40. Xuan, H.; Joseph, K.S.; Wa, C.; Hage, D. S. Biointeraction analysis of carbamazepine binding to alpha 1-acid glycoprotein by highperformance affinity chromatography. J. Sep. Sci., 2010, 33, 2294-2301.
41. Hage, D.S.; Jackson, A.; Sobansky, M.; Schiel, J.E.; Yoo, M.J.; Joseph, K.S. Characterization of drug-protein interactions in blood using high-performance affinity chromatography. J. Sep. Sci., 2009, 32, 835-853.
42. Mallik, R.; Hage, D. S. Affinity monolith chromatography. J. Sep. Sci., 2006, 29, 1686-1704. (Pubitemid 44340017)
43. Mallik, R.; Jiang, T.; Hage, D. S. High-performance affinity monolith chromatography: development & evaluation of human serum albumin columns. Anal. Chem, 2004, 76, 7013-7022. (Pubitemid 39600875)
44. nd Ed., Ellis Horwood, New York, 1991.
45. Andersson, S.; Thompson, R. A.; Allenmark, S. G. Direct liquid chromatographic separation of enantiomers on immobilized protein stationary phases. IX. Influence of the cross-linking reagent on the retentive and enantioselective properties of chiral sorbents based on bovine serum albumin. J. Chromatogr., 1992, 591, 65-73.
46. Thompson, R.A.; Andersson, S.; Allenmark, S. Direct liquid chromatographic separation of enantiomers on immobilized protein stationary phases. VII. Sorbents obtained by entrapment of cross- linked bovine serum albumin in silica. J. Chromatogr., 1989, 465, 263-270.
47. Ladaviere, C.; Delair, T.; Domard, A.; Pichot, C.; Mandrand, B. Covalent immobilization of bovine serum albumin onto (maleic anhydride-alt-methyl vinyl ether) copolymers. J. Appl. Polym. Sci., 1999, 72, 1565-1572.
48. Hermanson, G. T.; Mallia, A. K.; Smith, P.K., Immobilized Affinity Ligand Techniques; Academic Press: San Diego, 1992.
49. Mallik, R.; Jiang, T.; Hage, D. S. High-performance affinity monolith chromatography: development and evaluation of human serum albumin columns. Anal. Chem., 2004, 76, 7013-7022. (Pubitemid 39600875)
50. nd Ed.; D.S. Hage, Ed.; Taylor & Francis: New York, 2006; pp. 571-592.
51. Fournier, T.; Medjoubi-N, N.; Porquet, D. Alpha-1-acid glycopro- tein. Biochim. Biophys. Acta, 2000, 1482, 157-171.
52. Gottschalk, A., Glycoproteins: Their Composition, Structure and Function, Part A, 2nd ed.; Elsevier: New York 1972.
53. Kremer, J. M.; Wilting, J.; Janssen, L. H. M. Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol. Rev., 1988, 40, 1-47.
54. Aubry, A. F.; Gimenez, F.; Farinotti, R.; Wainer, I. W. Enantiose- lective chromatography of the antimalarial agents chloroquine, me- floquine, and enpiroline on a a1-acid glycoprotein chiral stationary phase: Evidence for a multiple-site chiral recognition mechanism. Chirality, 1992, 4, 30-35.
55. Mills, M. H.; Mather, L. E.; Gu, X. S.; Huang, J. L. Determination of ketorolac enantiomers in plasma using enantioselective liquid chromatography on an a1-acid glycoprotein chiral stationary phase and ultraviolet detection. J. Chromatogr. B., 1994, 658, 177-182. (Pubitemid 24261977)
56. Gyimesi-Forras, K.; Szasz, G.; Bathory, G.; Meszaros, G.; Gergely, A. Study on the sorption properties of a1-acid glycoprotein (AGP)- based stationary phase modified by organic solvents. Chirality, 2003, 15, 377-381. (Pubitemid 36523126)
57. Gotmar, G.; Albareda, N. R.; Fornstedt, T. Investigation of the heterogeneous adsorption behavior of selected enantiomers on immobilized alpha 1-acid glycoprotein. Anal. Chem., 2002, 74, 2950-2959. (Pubitemid 34755207)
58. Mallik, R.; Xuan, H.; Guiochon, G.; Hage, D. S. Immobilization of a1-acid glycoprotein for chromatographic studies of drug-protein binding II. correction for errors in association constant measurements. Anal. Biochem, 2008, 376, 154-156.
59. Allenmark, S. Chiral discrimination by albumin: A mechanistic study of liquid chromatographic optical resolution of nonaromatic carboxylic acids. Chirality, 1993, 5, 295-299. (Pubitemid 23261278)
60. Fitos, I.; Visy, J.; Simonyi, M.; Hermansson, J. Chiral highperformance liquid chromatographic separations of vinca alkaloid analogs on alpha 1-acid alycoprotein and human serum albumin columns. J. Chromatogr., 1992, 609, 163-171.
61. Barbato, F.; Di Martino, G.; Grumetto, L.; La Rotonda, M. I. Retention of quinolones on human serum albumin and a1-acid glycoprotein HPLC columns: relationships with different scales of lipophilicity. Eur. J. Pharmaceut. Sci., 2007, 30, 211-219. (Pubitemid 46282438)
62. Loeser, E.; Yowell, G.; Drumm, P. Effect of tertiary alcohol additives on enantioselectivity of the chiral-AGP column. J. Liq. Chromatogr. Rel. Technol., 2006, 29, 2625-2640. (Pubitemid 44395581)
63. Gyimesine Forras, K.; Gergely, A.; Kokosi, J. Enantioseparation of quinazolone derivatives using an AGP-based liquid chromatogra- phy stationary phase. Acta Pharmaceut. Hungarica, 2003, 73, 5-12. (Pubitemid 36505858)
64. Munro, J.; Gormley, J. P.; Walker, T. A. Bupropion hydrochloride: the development of a chiral separation using a chiral AGP column. J. Liq. Chromatogr. Rel. Technol., 2001, 24, 327-339. (Pubitemid 32290973)
65. Chen, S.; Sobansky, M.; Hage, D. S. Analysis of drug interactions with high-density lipoprotein by high-performance affinity chromatography. Anal. Biochem., 2010, 397, 107-114.
66. Barklay, M. In: Blood Lipids and Lipoproteins: Quantitation, Composition, and Metabolism.; Nelson, G.J., Ed.; Wiley: New York, 1972; pp. 587-603.
67. Jonas A. In: Biochemistry of Lipids, Lipoproteins and Membranes.; Vance, D.E., Vance, J.E., Eds.; Elsevier: Amsterdam, 2002; pp. 483-504.
68. Kostner, G.M. Human Plasma Lipoproteins; Walter de Gruyter: Berlin, 1989.
69. Wasan, K.; Cassidy, S.M. Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs. J. Pharm. Sci., 1998, 87, 411-424. (Pubitemid 28175800)
70. Harmony, J.A.K.; Aleson, A.L.; McCarthy, B.M. In: Biochemistry and Biology of Plasma Lipoproteins; Scanu, A.M.; Spector, A.A., Eds.; Marcel Dekker: New York, 1986; pp. 403-430.
71. Mbewu, A.; Durrington, P.N. Lipoprotein (a): structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis, 1990, 85, 1-14.
72. Durrington, P.N. In: Lipoproteins and Lipids; Durrington, P.N., Ed.; Wright: London, 1989; pp. 255-277.
73. Havel, R.J.; Kane, J.P. In: The Metabolic and Molecular Basis of Inherited Disease; Scriver, C.R.; Beaudet, A.L.; Sly, W.S.; Valle, D., Eds., McGraw-Hill: New York, 1995; pp.1129-1138.
74. Skipski, V.R. In: Blood Lipids and Lipoproteins: Quantitation Composition, and Metabolism; Nelson, G.J., Ed.; Wiley: New York, 1972; pp. 471-583.
75. Soltes, L. The Hummel-Dreyer method: impact in pharmacology. Biomed. Chromatogr., 2004, 18, 259-271. (Pubitemid 38801611)
76. nd Ed.; Taylor & Francis: New York, 2006, Chap. 2.
77. Hodgson, R. J.; Brook, M. A.; Brennan, J. D. Capillary-scale monolithic immunoaffinity columns for immunoextraction with inline laser-induced fluorescence detection. Anal. Chem., 2005, 77, 4404-4412. (Pubitemid 41542260)
78. Schiel, J.E.; Mallik, R.; Soman, S.; Joseph, K.S.; Hage, D.S. Applications of silica supports in affinity chromatography. J. Sep. Sci., 2006, 29, 719-737.
79. Yoo, M.J.; Hage, D.S. Affinity monolith chromatography: principles and recent developments. In: Monolithic Chromatography and Its Modern Applications; Wang, P., Ed.; ILM Publications: UK, 2010, Chap. 1.
80. Peters, E.C; Svec, F.; Frechet, J.M. Rigid macroporous polymer monoliths. J. Adv. Mater., 1999, 11, 1169-1181.
81. Luo, Q.; Zou, H.; Zhang, Q.; Xiao, X.; Ni, J. High-performance affinity chromatography with immobilization of protein A and L- histidine on molded monolith. Biotechnol. Bioeng., 2002, 80, 481-489. (Pubitemid 35285151)
82. Pan, Z; Zou, H.; Mo, W.; Huang, X.; Wu, R. Protein A immobilized monolithic capillary column for affinity chromatography. Anal. Chim. Acta, 2002, 466, 141-150. (Pubitemid 34874884)
83. Ostryanina, N.D.; Ill'ina, O.V.; Tennikova, T.B. Effect of experimental conditions on strong biocomplimentary pairing in high-performance monolithic disk affinity chromatography. J. Chromatogr. B., 2002, 770, 35-43. (Pubitemid 34266836)
84. Mallik, R.; Hage, D. S. Development of an affinity silica monolith containing human serum albumin for chiral separations. J. Pharm. Biomed. Anal., 2008, 46, 820-830. (Pubitemid 351400604)
85. Gupalova, T.V.; Lojkina, O.V.; Palagnuk, V.G.; Totolian, A. A.; Tennikova, T. B. Quantitative investigation of the affinity properties of different recombinant forms of protein G by means of highperformance monolithic chromatography. J. Chromatogr. A., 2002, 949, 185-193. (Pubitemid 34183426)
86. Freitag, R.; Splitt, H.; Reif, O.-W. Controlled mixed-mode interactions chromatography on membrane adsorbers. J. Chromatogr. A., 1996, 728, 129-137.
87. Yoo, M.J.; Hage, D.S. Evaluation of silica monoliths in affinity microcolumns for high-throughput analysis of drug-protein interactions. J. Sep. Sci., 2009, 32, 2776-2785.
88. Loun, B.; Hage, D. S. Characterization of thyroxine-albumin binding using high-performance affinity chromatography: I. Interactions at the warfarin and indole sites of albumin. J. Chromatogr., 1992, 579, 225-235.
89. Domenici, E.; Bertucci, C.; Salvadori, P.; Felix, G.; Cahagne, I.; Motellier, S.; Wainer, I. W. Synthesis and chromatographic properties of an HPLC chiral stationary phase based upon human serum albumin. Chromatographia, 1990, 29, 170-176.
90. Noctor, T. A. G.; Pham, C. D.; Kaliszan, R.; Wainer, I. W. Stereochemical aspects of benzodiazepine binding to human serum albumin. I. Enantioselective high performance liquid affinity chromatographic examination of chiral and achiral binding interactions between 1,4-benzodiazepines and human serum albumin. Mol. Pharmacol., 1992, 42, 506-511. (Pubitemid 23024671)
91. Noctor, T. A. G.; Wainer, I. W. Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography, on a human serum albumin-based stationary phase. J. Chromatogr., 1992, 577, 305-315.
92. Russeva, V. N.; Zhivkova, Z. D. Albumin binding sites studied by high-performance liquid affinity chromatography. Int. J. Pharmaceut., 1998, 168, 23-29. (Pubitemid 28293660)
93. Loun, B.; Hage, D. S., Chiral separation mechanisms in protein- based HPLC columns. I. Thermodynamic studies of R- and S- warfarin binding to immobilized human serum albumin. Anal. Chem., 1994, 66, 3814-3822.
94. Yang, J.; Hage, D. S. Characterization of the binding and chiral separation of D- and L-tryptophan on a high-performance immobilized human serum albumin column. J. Chromatogr., 1993, 645, 241-250. (Pubitemid 23246924)
95. Mallik, R.; Yoo, M. J.; Chen, S.; Hage, D. S. Studies of verapamil binding to human serum albumin by high-performance affinity chromatography. J. Chromatogr. B., 2008, 876, 69-75.
96. Kim, H. S.; Wainer, I. W. Rapid analysis of the interactions between drugs and human serum albumin (HSA) using highperformance affinity chromatography (HPAC). J. Chromatogr. B., 2008, 870, 22-26.
97. Loun, B.; Hage, D. S. Chiral separation mechanisms in protein- based HPLC columns. II. Kinetic studies of R- and S-warfarin binding to immobilized human serum albumin. Anal. Chem., 1996, 68, 1218-1225.
98. Yang, J.; Hage, D. S. Effect of mobile phase composition on the binding kinetics of chiral solutes on a protein-based HPLC column: interactions of D- and L-tryptophan with immobilized human serum albumin. J. Chromatogr. B., 1997, 766, 15-25. (Pubitemid 27166330)
99. Yang, J.; Hage, D. S. Role of binding capacity versus binding strength in the separation of chiral compounds by protein-based HPLC. J. Chromatogr. A., 1996, 725, 273-285.
100. 1- Acid glyco- protein high-performance liquid chromatography column (Enantio PAC) as a screening tool for protein binding. J. Chromatogr., 1989, 487, 257-264. (Pubitemid 19147198)
101. Schill, G.; Wainer, I. W.; Barkan, S. A. Chiral separations of cati- onic and anionic drugs on a1-acid glycoprotein-bonded stationary phase (Enantiopac®): II. Influence of mobile phase additives and pH on chiral resolution and retention. J. Chromatogr., 1986, 365, 73-88. (Pubitemid 16032222)
102. nd Ed.; D.S. Hage, Ed.; Taylor & Francis, New York, 2006, Chap. 3.
103. Harada, K.; Yuan, Q.; Nakayama, M.; Sugii, A. Effects of organic modifiers on the chiral recognition by different types of silicaimmobilized bovine serum albumin. J. Chromatogr. A., 1996, 740, 207-213. (Pubitemid 26281017)
104. Tittelbach, V.; Gilpin, R. K. Species dependency of the liquid chromatographic properties of silica-immobilized serum albumins. Anal. Chem., 1995, 67, 44-47.
105. Tittelbach, V.; Jaroniec, M.; Gilpin, R. K. Synthesis and characterization of silica-immobilized serum albumin stationary phases for HPLC. J. Liq. Chromatogr. Rel. Technol., 1996, 19, 2943-2965. (Pubitemid 26344574)
106. Millot, M. C.; Sebille, B.; Mangin, C. Enantiomeric properties of human albumin immobilized on porous silica supports coated with polymethacryloyl chloride. J. Chromatogr. A., 1997, 776, 37-44. (Pubitemid 27336972)
107. Kim, H. S.; Kye, Y. S.; Hage, D. S. Development and evaluation of N-hydroxysuccinimide-activated silica for immobilizing human serum albumin in liquid chromatography columns. J. Chromatogr. A., 2004, 1049, 51-61. (Pubitemid 39208788)
108. Kim, H. S.; Mallik, R.; Hage, D. S. Chromatographic analysis of carbamazepine binding to human serum albumin. J. Chromatogr. B., 2006, 837, 138-146.
109. Taleb, N. L.; Millot, M. C.; Sebille, B. Enantioselectivity properties of human serum albumin immobilized on anion-exchangers based on polyvinylimidazole-coated silica. Effect of protein loading on separation properties. J. Chromatogr. A., 1997, 776, 45-53. (Pubitemid 27336973)
110. Fitos, I.; Visy, J.; Simonyi, M.; Hermansson, J. Chiral highperformance liquid chromatographic separations of vinca alkaloid analogs on a1-acid glycoprotein and human serum albumin columns. J. Chromatogr., 1992, 609, 163-171.
111. Simek, Z.; Vespalec, R. Interpretation of enantioselective activity of albumin used as the chiral selector in liquid chromatography and electrophoresis. J. Chromatogr. A., 1994, 685, 7-14. (Pubitemid 24366458)
112. Simek, Z.; Vespalec, R. Chromatographic properties of chemically bonded bovine serum albumin working as a chiral selector in alkaline mobile phases. J. Chromatogr., 1993, 629, 153-160. (Pubitemid 23029255)
113. Mallik, R.; Wa, C.; Hage, D. S. Development of sulfhydryl-reactive silica for protein immobilization in high-performance affinity chromatography. Anal. Chem., 2007, 79, 1411-1424.
114. Vera-Avila, L. E.; Garcia-Salgado, E.; Garcia de Llasera, M. P.; Pena-Alvarez, A. Binding characteristics of bovine serum albumin encapsulated in sol-gel glasses: an alternative for protein interaction studies. Anal. Biochem., 2008, 373, 272-280.
115. Jackson, A.J. ; Xuan, H.; Hage, D.S. Entrapment of proteins in glycogen-capped and hydrazide-activated supports, Anal. Biochem., 2010, 404, 106-108.
116. Mallik, R.; Xuan, H.; Guiochon, G.; Hage, D. S. Immobilization of a1-acid glycoprotein for chromatographic studies of drug-protein binding. II. Correction for errors in association constant measurements. Anal. Biochem, 2008, 376, 154-156.
117. Nakano, N. I.; Shimamori, Y.; Yamaguchi, S. Binding capacities of human serum albumin monomer and dimer by continuous frontal affinity chromatography. J. Chromatogr., 1982, 237, 225-232. (Pubitemid 12111785)
118. Joseph, K.S.; Hage, D.S. The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan. J. Pharm. Biomed. Anal., 2010, 53, 811-818.
119. Joseph, K.S.; Anguizola, J.; Hage, D.S. Chromatographic analysis of acetohexamide binding to glycated human serum albumin. J. Chromatogr. B., 2010, 878, 2775-2781.
120. Joseph, K.S.; Anguizola, J.; Hage, D.S. Binding of tolbutamide to glycated human serum albumin. J. Pharm. Biomed. Anal., 2011, 54, 426-432.
121. Noctor, T. A. G.; Wainer, I. W. The in situ acetylation of an immobilized human serum albumin chiral stationary phase for highperformance liquid chromatography in the examination of drug-protein binding phenomena.Pharm. Res., 1992, 9, 480-484.
122. Chattopadhyay, A.; Tian, T.; Kortum, L.; Hage, D. S. Development of tryptophan-modified human serum albumin columns for site- specific studies of drug-protein interactions by high-performance affinity chromatography. J. Chromatogr. B., 1998, 715, 183-190. (Pubitemid 28403610)
123. Joseph, K.S.; Hage, D.S. Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography. J. Chromatogr. B., 2010, 878, 1590-1598.
124. Schiel, J.E.; Hage, D.S. Kinetic studies of biological interactions by affinity chromatography. J. Sep. Sci., 2009, 32, 1507-1522.
125. Talbert, A. M.; Tranter, G. E.; Holmes, E.; Francis, P. L. Determination of drug-plasma protein binding kinetics and equlibria by chromatographic profiling: exemplification of a method using tryptophan and albumin. Anal. Chem., 2002, 74, 446-452. (Pubitemid 34072713)
126. Schiel, J. E.; Ohnmacht, C. M.; Hage, D. S. Measurement of drug- protein dissociation rates by high-performance affinity chromatography and peak profiling. Anal. Chem, 2009, 81, 4320-4333.
127. Moore, R. M.; Walters, R. R. Peak-decay method for the measurement of dissociation rate constants by high-performance affinity chromatography. J. Chromatogr., 1987, 384, 91-103.
128. Chen, J.; Schiel, J.E.; Hage, D.S. Non-competitive peak decay analysis of drug-protein dissociation by high-performance affinity chromatography and peak profiling. J. Sep. Sci., 2009, 32, 1632-1641.
129. Yoo, M.J.; Hage, D.S. Use of peak decay analysis and affinity microcolumns containing silica monoliths for rapid determination of drug-protein dissociation rates. J. Chromatogr. A., in press.
130. Clarke, W.; Chowdhuri, A. R.; Hage, D. S. Analysis of free drug fractions by ultra-fast immunoaffinity chromatography. Anal. Chem., 2001, 73, 2157-2164. (Pubitemid 32880677)
131. Clarke, W.; Schiel, J. E.; Moser, A.; Hage, D. S. Analysis of free hormone fractions by an ultrafast immunoextraction/displacement immunoassay: studies using free thyroxine as a model system. Anal. Chem., 2005, 77, 1859-1866. (Pubitemid 40396285)
132. Ohnmacht, C. M.; Schiel, J. E.; Hage, D. S. Analysis of free drug fractions using near-infrared fluorescent labels and an ultrafast immunoextraction/displacement assay. Anal. Chem., 2006, 78, 7547-7556. (Pubitemid 44707664)
133. Mallik, R.; Yoo, M.J.; Briscoe, C.J.; Hage, D.S. Analysis of drug- protein binding by ultrafast affinity chromatography using immobilized human serum albumin. J. Chromatogr. A., 2010, 1217, 2796-2803.
134. Noctor, T.A.G.; Diaz-Perez, M.J.; Wainer, I.W. Use of a human serum albumin-based stationary phase for high-performance liquid chromatography as a tool for the rapid determination of drugplasma protein binding. J. Pharm. Sci., 1993, 82, 675-676. (Pubitemid 23216022)
135. Beaudry, F.; Coutu, M.; Brown, N. K. Determination of drugplasma protein binding using human serum albumin chromatographic column and multiple linear regression model. Biomed. Chromatogr., 1999, 13, 401-406. (Pubitemid 29462161)
136. Tiller, P. R.; Mutton, I. M.; Lane, S. J.; Bevan, C. D. Immobilized human serum albumin: liquid chromatography/mass spectrometry as a method of determining drug-protein binding. Rapid Commun. Mass Spectrom, 1995, 9, 261-263.
137. Briscoe, C.J. Advances in the Application of High Performance Affinity Chromatography to Bioanalysis and Approaches for Improving the Quality and Reliability of Bioanalytical Data. PhD Thesis, University of Nebraska: Lincoln, Nebraska, 2009.
138. Yoo, M.J.; Schiel, J.E.; Hage, D.S. Evaluation of affinity microcolumns containing human serum albumin for rapid analysis of drug- protein binding. J. Chromatogr. B, 2010, 878, 1707-1713.
139. Chen, J.; Hage, D. S. Quantitative analysis of allosteric drug- protein binding by bio-interaction chromatography. Nature Biotechnol, 2004, 22, 1445-1448. (Pubitemid 39482866)
140. Chen, J.; Fitos, I.; Hage, D. S. Chromatographic analysis of allosteric effects between ibuprofen and benzodiazepines on human serum albumin. Chirality, 2006, 18, 24-36. (Pubitemid 43031136)
141. Chen, J.; Hage, D. S. Quantitative studies of allosteric effects by biointeraction chromatography: analysis of protein binding for low-solubility drugs. Anal. Chem., 2006, 78, 2672-2683.
142. Nakano, N. I.; Shimamori, Y.; Yamaguchi, S. Mutual displacement interactions in the binding of two drugs to human serum albumin by frontal affinity chromatography. J. Chromatogr., 1980, 188, 347-356. (Pubitemid 10110758)
143. Gyimesine Forras, K.; Gergely, A.; Kokosi, J. Enantioseparation of quinazolone derivatives using an AGP-based liquid chromatogra- phy stationary phase. Acta Pharmaceut. Hungarica, 2003, 73, 5-12. (Pubitemid 36505858)
144. Munro, J.; Gormley, J. P.; Walker, T. A. Bupropion hydrochloride: the development of a chiral separation using a chiral AGP column. J. Liq. Chromatogr. Rel. Technol., 2001, 24, 327-339. (Pubitemid 32290973)
145. Gyimesi-Forras, K.; Szasz, G.; Gergely, A.; Szabo, M.; Kokosi, J. Optical resolution of a series of potential cholecystokinin antagonist 4(3H)-quinazolone derivatives by chiral liquid chromatography on α1-acid glycoprotein stationary phase. J. Chromatogr. Sci., 2000, 38, 430-434. (Pubitemid 34982770)
146. Wang, H.; Zou, H.; Ni, J.; Guo, B. Comparative separation of biologically active components in Rhizoma chuanxiong by affinity chromatography with cd-acid glycoprotein and human serum albumin as stationary phases. Chromatographia, 2000, 52, 459-464.
147. Kim, H. S.; Hage, D. S. Chromatographic analysis of carba- mazepine binding to human serum albumin. J. Chromatogr. B., 2005, 816, 57-66. (Pubitemid 40143490)
148. Yang, J.; Hage, D. S. Characterization of the binding and chiral separation of D- and L-tryptophan on a high-performance immobilized human serum albumin column. J. Chromatogr., 1993, 645, 241-250. (Pubitemid 23246924)
149. Peyrin, E.; Guillaume, Y. C.; Guinchard, C. Interactions between dansyl amino acids and human serum albumin using highperformance liquid chromatography: mobile-phase pH and temperature considerations. Anal. Chem., 1997, 69, 4979-4984.
150. Peyrin, E.; Guillaume, Y. C.; Morin, N.; Guinchard, C.; Retention behavior of d,l-dansyl-amino acids on a human serum albumin chiral stationary phase: effect of a mobile phase modifier. J. Chromatogr. A, 1998, 808, 113-120. (Pubitemid 28273225)
151. Gilpin R. K.; Ehtesham, S. E.; Gregory, R. B. Liquid chromatographic studies of the effect of temperature on the chiral recognition of tryptophan by silica-immobilized bovine albumin. Anal. Chem., 1991, 63, 2825-2828.
152. Gilpin, R. K.; Ehtesham, S. B.; Gilpin, C. S.; Liao, S. T. Liquid chromatographic studies of memory effects of silica-immobilized bovine serum albumin: I. Influence of methanol on solute retention. J. Liq. Chromatogr. Rel. Technol., 1996, 19, 3023-3035. (Pubitemid 26344578)
153. Peyrin, E.; Guillaume, Y. C.; Morin, N.; Guinchard, C. Sucrose dependence of solute retention on human serum albumin stationary phase: hydrophobic effect and surface tension considerations. Anal. Chem., 1998, 70, 2812-2818.
154. Su, W.; Gregory, R. B.; Gilpin, R. K. Liquid chromatographic studies of silica-immobilized HEW lysozyme. J. Chromatogr. Sci., 1993, 31, 285-290. (Pubitemid 23675443)
155. Peyrin, E.; Guillaume, Y. C.; Guinchard, C. Peculiarities of dansyl amino acid enantioselectivity using human serum albumin as a chiral selector. J. Chromatogr. Sci., 1998, 36, 97-103. (Pubitemid 128479015)
156. Peyrin, E.; Guillaume, Y. C. Chiral discrimination of N-(dansyl)- DL-amino acids on human serum albumin stationary phase. Effect of a mobile phase modifier. Chromatographia, 1998, 48, 431-435. (Pubitemid 28439379)
157. Rahim, S.; Aubry, A.-F. Location of binding sites on immobilized human serum albumin for some nonsteroidal anti-inflammatory drugs. J. Pharm. Sci., 1995, 84, 949-952.
158. Aubry, A.-F.; Markoglou, N.; McGann, A. Comparison of drug binding interactions on human, rat and rabbit serum albumin using high-performance displacement chromatography. Comp. Biochem. Physiol., 1995, 112, 257-266. (Pubitemid 26038863)
159. Hage, D. S.; Noctor, T. A. G.; Wainer, I. W. Characterization of the protein binding of chiral drugs by high-performance affinity chromatography. Interactions of R- and S-ibuprofen with human serum albumin. J. Chromatogr. A., 1995, 693, 23-32.
160. Hage, D. S.; Sengupta, A. Studies of protein binding to nonpolar solutes by using zonal elution and high-performance affinity chromatography: interactions of cis- and trans-clomiphene with human serum albumin in the presence of β-cyclodextrin. Anal. Chem., 1998, 70, 4602-4609.
161. Hage, D. S.; Sengupta, A. Characterization of the binding of digitoxin and acetyldigitoxin to human serum albumin by highperformance affinity chromatography. J. Chromatogr. B., 1999, 724, 91-100. (Pubitemid 29146024)
162. Sengupta, A.; Hage, D. S. Characterization of minor site probes for human serum albumin by high-performance affinity chromatography. Anal. Chem., 1999, 71, 3821-3827.
163. Chen, J.; Ohnmacht, C.; Hage, D. S. Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography. J. Chromatogr. B, 2004, 809, 137-145. (Pubitemid 38998431)
164. Loun, B.; Hage, D. S. Characterization of thyroxine-albumin binding using high-performance affinity chromatography. II. Comparison of the binding of thyroxine, triiodothyronines and related compounds at the warfarin and indole sites of human serum albumin. J. Chromatogr. B, 1995, 665, 303-314.
165. Joseph, K. S.; Moser, A. C.; Basiaga, S.B.G.; Schiel, J. E.; Hage, D. S. Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin. J. Chromatogr. A., 2009, 1216, 3492-3500.
166. Conrad, M. L.; Moser, A. C.; Hage, D. S. Evaluation of indole- based probes for high-throughput screening of drug binding to human serum albumin: analysis by high-performance affinity chromatography. J. Sep. Sci., 2009, 32, 1145-1155.
167. Kaliszan, R. Retention data from affinity high-performance liquid chromatography in view of chemometrics. J. Chromatogr. B., 1998, 775, 229-244. (Pubitemid 28403614)
168. Wainer, I. W. Enantioselective high-performance liquid affinity chromatography as a probe of ligand-biopolymer interactions: an overview of a different use for high-performance liquid Chromatographic chiral stationary phases. J. Chromatogr. A., 1994, 666, 221-234. (Pubitemid 24138214)
169. Markuszewski, M.; Kaliszan, R. Quantitative structure-retention relationships in affinity high-performance liquid chromatography. J. Chromatogr. B, 2002, 768, 55-66. (Pubitemid 34142296)
170. Kaliszan, R.; Noctor, T. A. G.; Wainer, I. W. Stereochemical aspects of benzodiazepine binding to human serum albumin. I. Enantioselective high performance liquid affinity chromatographic examination of chiral and achiral binding interactions between 1,4- benzodiazepines and human serum albumin. Mol. Pharmacol., 1992, 42, 512-517. (Pubitemid 23024672)
171. Andrisano, V.; Gotti, R.; Recanatini, M.; Cavalli, A.; Varoli, L.; Bertucci, C. Stereoselective binding of 2-(4-biphenylyl)-3- substituted-3- hydroxy-propionic acids on an immobilised human serum albumin chiral stationary phase. J. Chromatogr. B., 2002, 768, 137-145. (Pubitemid 34142305)
172. Andrisano, V.; Bertucci, C.; Cavrini, V.; Recanatini, M.; Cavalli, A.; Varoli, L.; Felix, G.; Wainer, I. W. Stereoselective binding of 2,3-substituted 3-hydroxypropionic acids on an immobilized human serum albumin chiral stationary phase: stereochemical characterization and quantitative structure-retention relationship study. J. Chromatogr. A., 2000, 876, 75-86. (Pubitemid 30211551)
173. Fitos, I.; Visy, J.; Simonyi, M.; Hermansson, J. Chiral highperformance liquid chromatographic separations of vinca alkaloid analogs on alpha 1-acid alycoprotein and human serum albumin columns. J. Chromatogr., 1992, 609, 163-171.
174. Barbato, F.; Di Martino, G.; Grumetto, L.; La Rotonda, M. I. Retention of quinolones on human serum albumin and α1-acid glycoprotein HPLC columns: relationships with different scales of lipophilicity. Eur. J. Pharmaceut. Sci., 2007, 30, 211-219. (Pubitemid 46282438)
175. Karlsson, A.; Aspegren, A. Enantiomeric separation of amino alcohols on protein phases using statistical experimental design - a comparative study. J. Chromatogr. A., 2000, 866, 15-23. (Pubitemid 30001845)
176. Kaliszan, R.; Nasal, A.; Turowski, M. Binding site for basic drugs on cd-acid glycoprotein as revealed by chemometric analysis of biochromatographic data. Biomed. Chromatogr., 1995, 707, 211-215.
177. Kaliszan, R.; Nasal, A.; Turowski, M. Quantitative structure- retention relationships in the examination of the topography of the binding site of antihistamine drugs on a1-acid glycoprotein. J. Chromatogr. A., 1996, 722, 25-32.
178. Nasal, A., Radwanska, A.; Osmialowski, K.; Bucinski, A.; Kaliszan, R.; Barker, G.E.; Sun, P.; Hartwick, R.A. Quantitative relationships between the structure of adrenolytic and antihistamine drugs and their retention on an a1-acid glycoprotein HPLC column. Biomed. Chromatogr., 1994, 8, 125-129. (Pubitemid 24157590)
179. Bertucci, C.; Wainer, I. W. Improved chromatographic performance of a modified human albumin based stationary phase. Chirality, 1997, 9, 335-340. (Pubitemid 27338089)
180. Haginaka, J.; Kanasugi, N. Enantioselectivity of bovine serum albumin-bonded columns produced with isolated protein fragments. II. Characterization of protein fragments and chiral binding sites. J. Chromatogr. A., 1997, 769, 215-223. (Pubitemid 27212321)
181. Haginaka, J.; Kanasugi, N. Enantioselectivity of bovine serum albumin-bonded columns produced with isolated protein fragments. J. Chromatogr. A., 1995, 694, 71-80.
182. Slon-Usakiewicz, J.J.; Ng, W.; Dai, J.-R.; Pasternak, A.; Redden, P.R. Frontal affinity chromatography with MS detection (F AC-MS) in drug discovery. Drug Discovery Today, 2005, 70, 409-416. (Pubitemid 40444656)
183. Valko, K.; Nonhuck, S.; Bevan, C.; Abraham, M.H.; Reynolds, D.P. Fast gradient HPLC method to determine compounds binding to human serum albumin. Relationships with octanol/water and immobilized artificial membrane lipophilicity. J. Pharm. Sci., 2003, 92, 2236-2248. (Pubitemid 37356697)